Matias Cordoba

• Lead the global medical strategy for the launch of a first-in-class BTK inhibitor targeting immune-mediated rare blood disorders, including ITP, wAIHA, and SCD.
• Collaborate with global and regional teams to ensure alignment and successful execution of medical plans.
• Partner with local teams to address high unmet medical needs and drive impactful outcomes.
• Engage with multiple stakeholders, including regulatory bodies, healthcare professionals, and patient advocacy groups.
• Oversee complex processes and ensure compliance with regulatory standards.

• Developed and implemented a comprehensive global medical strategy, ensuring seamless alignment with country medical leads.
• Key responsibilities included launch preparedness, KOL engagement, and execution of medical education plans.

• Planned and implemented the medical strategy for a biologic launch product across multiple therapeutic areas, including atopic dermatitis, asthma, and nasal polyps (Argentina, Chile & Uruguay)
• Managed a team of MSLs to cover field-based medical needs based on a solid Scientific Engagement Model.

• Designed and implemented the Regional Brand Plan for the therapeutic area, providing guidance and support to local teams across South America.
• Fostered collaborative relationships with opinion leaders, medical community, and academic centers.

Provided medical expertise and collaborated on clinical trials, focusing on patient recruitment and engagement with the medical community.